SC
ORIC icon

Steven Cohen’s Oric Pharmaceuticals ORIC Stock Holding History

Steven Cohen’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,923,077
Closed -$23.9M – 4287
2025
Q4 		$23.9M Buy
2,923,077
+303,163
+12% +$3.49M 0.03% 781
2025
Q3 		$31.4M Sell
2,619,914
-230,727
-8% -$2.43M 0.05% 389
2025
Q2 		$28.9M Buy
+2,850,641
New +$19.1M 0.06% 379
2024
Q1 		– Sell
-521,142
Closed -$4.79M – 2505
2023
Q4 		$4.79M Buy
+521,142
New +$3.77M 0.01% 941
2023
Q2 		– Sell
-5,642
Closed -$32.2K – 2612
2023
Q1 		$32.2K Sell
5,642
-13,458
-70% -$70.3K ﹤0.01% 1881
2022
Q4 		$112K Buy
19,100
+9,100
+91% +$30.7K ﹤0.01% 1298
2022
Q3 		$32K Buy
+10,000
New +$40K ﹤0.01% 1321
2022
Q2 		– Sell
-7,800
Closed -$42K – 1571
2022
Q1 		$42K Buy
+7,800
New +$70.2K ﹤0.01% 1088
2021
Q4 		– Sell
-333,782
Closed -$6.98M – 1239
2021
Q3 		$6.98M Sell
333,782
-610,219
-65% -$12.4M 0.03% 584
2021
Q2 		$16.7M Sell
944,001
-341,646
-27% -$7.49M 0.08% 329
2021
Q1 		$31.5M Buy
+1,285,647
New +$40.6M 0.15% 183

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Steven Cohen's ORIC Position: Q1 2026 in Review

Steven Cohen sold out of Oric Pharmaceuticals (ORIC) in Q1 2026, closing a stake of 2,923,077 shares — an estimated $23.9M sold.

Steven Cohen first reported a position in ORIC in Q1 2021 and held it in 11 quarters. The position peaked at $31.5M in Q1 2021. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Steven Cohen reported no remaining Oric Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Steven Cohen sold 2,923,077 Oric Pharmaceuticals shares in Q1 2026, an estimated $23.9M.
  • Steven Cohen first reported a position in Oric Pharmaceuticals in Q1 2021 and held it in 11 quarters.
  • Steven Cohen's Oric Pharmaceuticals position peaked at $31.5M in Q1 2021.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.